Skip to main content

Nonadherence, Patient clinical trials at UC Health
1 research study open to new patients

  • Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence

    open to eligible people ages 18 years and up

    This study evaluates the ability of digital medicines, Proteus Discover, to promote adherence and thus achieving a cure for hepatitis C in patients at high risk for not adhering to their hepatitis therapy. In this single-arm, prospective study, subjects at high risk for nonadherence will be prescribed hepatitis C therapy that will be co-encapsulated with ingestible sensors (creating the digital medicine) by a pharmacy. Both the subject and the providers will have access to the ingestion adherence.

    at UCSF

Last updated: